CYBER HORNET ETFs LLC Increases Stake in Cardinal Health, Inc. $CAH

CYBER HORNET ETFs LLC lifted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 430.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,462 shares of the company’s stock after buying an additional 2,809 shares during the quarter. CYBER HORNET ETFs LLC’s holdings in Cardinal Health were worth $822,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. California State Teachers Retirement System increased its position in shares of Cardinal Health by 22,881.2% in the 2nd quarter. California State Teachers Retirement System now owns 85,193,767 shares of the company’s stock valued at $20,238,631,000 after purchasing an additional 84,823,056 shares during the last quarter. Nilsine Partners LLC raised its stake in Cardinal Health by 437.7% in the second quarter. Nilsine Partners LLC now owns 6,049 shares of the company’s stock valued at $1,437,000 after buying an additional 4,924 shares in the last quarter. Saudi Central Bank raised its stake in Cardinal Health by 87.8% in the second quarter. Saudi Central Bank now owns 16,472 shares of the company’s stock valued at $3,913,000 after buying an additional 7,702 shares in the last quarter. Compass Financial Management LLC purchased a new stake in Cardinal Health during the 2nd quarter worth about $1,526,000. Finally, NBH Bank purchased a new stake in Cardinal Health during the 2nd quarter worth about $31,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Cardinal Health news, CEO Stephen M. Mason sold 35,000 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the completion of the transaction, the chief executive officer owned 18,061 shares in the company, valued at approximately $4,269,620.40. The trade was a 65.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jason M. Hollar sold 80,000 shares of the company’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $235.74, for a total transaction of $18,859,200.00. Following the completion of the sale, the chief executive officer directly owned 235,132 shares in the company, valued at $55,430,017.68. This trade represents a 25.39% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 210,271 shares of company stock valued at $49,626,657 in the last 90 days. 0.12% of the stock is owned by corporate insiders.

Cardinal Health Stock Performance

Shares of CAH opened at $246.67 on Monday. The company has a market capitalization of $57.37 billion, a price-to-earnings ratio of 34.12, a price-to-earnings-growth ratio of 1.49 and a beta of 0.51. Cardinal Health, Inc. has a fifty-two week low of $145.87 and a fifty-two week high of $258.30. The firm has a 50-day simple moving average of $234.23 and a 200-day simple moving average of $219.17.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The firm had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. During the same period in the prior year, the business earned $2.08 EPS. The firm’s revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Equities research analysts forecast that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be paid a $0.5158 dividend. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.8%. Cardinal Health’s payout ratio is 28.49%.

Analyst Ratings Changes

CAH has been the topic of a number of recent analyst reports. UBS Group increased their price objective on Cardinal Health from $274.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Mizuho upped their price target on Cardinal Health from $240.00 to $250.00 and gave the company an “outperform” rating in a report on Wednesday, August 12th. TD Cowen increased their price target on shares of Cardinal Health from $275.00 to $280.00 and gave the company a “buy” rating in a research note on Thursday, August 13th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Cardinal Health from $215.00 to $260.00 and gave the stock a “neutral” rating in a report on Thursday, August 13th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $266.56.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.